GAF Healthcare
Обзор направления

Лучшие больницы для «Bilateral Hand Transplant» в Хайдарабад, Индия

4 больниц по направлению «Трансплантация печени и гепатобилиарная хирургия» представлены в нашей сети в Индия, Хайдарабад, с аккредитацией JCI, NABH.

4
больниц в списке
1
город
4.5
средний рейтинг
2
вида аккредитации
Короткий ответ

На этой странице перечислены больницы направления «Трансплантация печени и гепатобилиарная хирургия» (включая Bilateral Hand Transplant) в Хайдарабад, Индия, включая KIMS Hospitals, Secunderabad, Yashoda Hospitals, Secunderabad, Apollo Hospital DRDO, Apollo Hospitals, Jubilee Hills.

Спросите нас о «Bilateral Hand Transplant» в Хайдарабад, Индия

Оставьте свои данные — наша команда координации свяжется с вами и расскажет о следующих шагах.

Сравните 4 аккредитованных больниц (Трансплантация печени и гепатобилиарная хирургия) в Хайдарабад, Индия

🇮🇳 KIMS Hospitals, Secunderabad

Hyderabad, India 4.8 (743 отзывов) 8,300 коек
Почему стоит выбрать эту больницу?
Рейтинг 4.8 из 5 (743 отзывов)Аккредитация: JCI, NABH8,300 коек
Специализации и аккредитация
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsNephrology
Аккредитация JCI, NABH
4.8/5
Рейтинг
2000
Основана в
8,300
Койки
Hyderabad, India
Расположение
Yashoda Hospitals, Secunderabad

🇮🇳 Yashoda Hospitals, Secunderabad

Secunderabad, Hyderabad, India 4.7 (518 отзывов) 1,026 коек
Почему стоит выбрать эту больницу?
Рейтинг 4.7 из 5 (518 отзывов)Аккредитация: NABH1,026 коек
Специализации и аккредитация
Cardiac SurgeryCardiologyNeurologyOrthopedicsOncologyGastroenterology
Аккредитация NABH
4.7/5
Рейтинг
1989
Основана в
1,026
Койки
Secunderabad, Hyderabad, India
Расположение
Apollo Hospital DRDO

🇮🇳 Apollo Hospital DRDO

Kanchan Bagh, Hyderabad, India 4.5 (82 отзывов) 200 коек
Почему стоит выбрать эту больницу?
Рейтинг 4.5 из 5 (82 отзывов)Аккредитация: NABH, JCI200 коек
Специализации и аккредитация
Cardiac SciencesOrthopedicsOncologyNeurosciencesTransplant
Аккредитация NABH, JCI
4.5/5
Рейтинг
2001
Основана в
200
Койки
Kanchan Bagh, Hyderabad, India
Расположение
Apollo Hospitals, Jubilee Hills

🇮🇳 Apollo Hospitals, Jubilee Hills

Hyderabad, India 4.1 (44 отзывов) 550 коек
Почему стоит выбрать эту больницу?
Рейтинг 4.1 из 5 (44 отзывов)Аккредитация: JCI, NABH550 коек
Специализации и аккредитация
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Аккредитация JCI, NABH
4.1/5
Рейтинг
1988
Основана в
550
Койки
Hyderabad, India
Расположение
Наша методология

Как мы выбираем эти больницы

Больница появляется на этой странице, если направление «Трансплантация печени и гепатобилиарная хирургия» указано среди её специализаций и она находится в Хайдарабад, Индия. Сортировка — по указанному рейтингу (по убыванию), без редакционного рейтинга «лучших».

На что обратить внимание

Как выбрать лучшую больницу для «bilateral hand transplant» в Хайдарабад, Индия?

Выбор подходящей больницы для «bilateral hand transplant» — важное решение в вашем пути лечения. Вот на что стоит обратить внимание:

Международная аккредитация

Ищите больницу с международной аккредитацией, например JCI или NABH — см. отметки аккредитации у каждой больницы ниже.

Специализация

Убедитесь, что в больнице есть отделение, специализирующееся на «Трансплантация печени и гепатобилиарная хирургия», а не только общая помощь.

Мощность и опыт

Количество коек и год основания, указанные ниже, отражают масштаб и операционный опыт больницы.

Прозрачность стоимости

Запросите детализированную смету перед поездкой — используйте наш калькулятор стоимости для первичной оценки.

Клинический обзор

Что нужно знать о процедуре «Bilateral Hand Transplant»

Bilateral Hand Transplant, formally classified as Composite Tissue Allotransplantation (CTA) of the upper extremity, is one of the most complex reconstructive surgeries in modern medicine, requiring simultaneous restoration of bone, tendon, nerve, vessel, and skin across both limbs under a single anesthetic event often lasting 12–16 hours. Global outcomes data from the International Registry on Hand and Composite Tissue Transplantation (IRHCTT) report functional success rates of approximately 85–90% at five years when patients are enrolled in structured immunosuppression and hand therapy protocols. GAF Healthcare connects international patients with India's and the UAE's leading Plastic & Reconstructive Surgery centers — offering NABH/JCI-accredited expertise in India at a fraction of Western costs, and JCI/DHA-accredited luxury-tier care in Dubai and Abu Dhabi for patients who prioritize premium infrastructure and geographic convenience.

21–35 days (acute surgical admission, including ICU and step-down ward)
Hospital Stay
12–16 weeks minimum before cleared for long-haul international flight (hand therapy milestones, immunosuppression stabilization, and wound integrity must be confirmed by the treating team)
Total Stay in Country (Fit-to-Fly)
85–90% functional graft survival at 5 years (per IRHCTT registry data)
Success Rate

Clinical Overview

Bilateral hand transplantation addresses traumatic or congenital bilateral upper-limb amputations at the wrist, transcarpal, or distal forearm level. Unlike solid organ transplants, CTA involves the transfer of a vascularized composite allograft (VCA) — a unit containing skin, subcutaneous tissue, fascia, muscle, tendon, nerve, bone, and cartilage — from a brain-dead, heart-beating deceased donor whose ABO blood group and HLA profile are matched to the recipient. The physiological consequence of bilateral hand loss extends far beyond motor deficit: patients experience profound disruption of proprioception, fine-touch discrimination, thermal sensing, and grip strength, resulting in a near-total dependence on caregivers for activities of daily living (ADLs). Neuropsychological sequelae — including phantom limb pain, post-traumatic stress disorder, and depression — are documented in over 60% of bilateral amputees, underscoring the urgency of functional restoration.

Подробнее →

Who is a Candidate?

Eligibility Criteria

  • Bilateral upper-limb amputation at or proximal to the radiocarpal (wrist) joint, with documented failure or inadequacy of prosthetic rehabilitation
  • Age range: 18–60 years (pediatric cases evaluated individually; elderly patients excluded due to immunosuppression risk-benefit ratio)
  • Adequate residual forearm musculature to enable motor re-innervation; ideally amputation level distal to the elbow (trans-radial or transcarpal)
  • Documented stable psychiatric status: absence of active psychosis, substance use disorder, or personality disorders that would compromise medication adherence
  • Strong social support network and confirmed commitment to a 12–24 month intensive hand therapy program
  • +3 more

Required Pre-operative Diagnostics

Подробнее →

Treatment Options & Approaches

PHASE 1 — DONOR Procurement AND Allograft Preparation

The procedure is initiated only upon confirmation of a brain-dead, hemodynamically stable donor with compatible HLA/ABO profile and negative cross-match. Ischemia time is the critical variable: warm ischemia must not exceed 6 hours, and cold ischemic time (with perfusion using University of Wisconsin or HTK solution) should ideally remain below 4–6 hours to maximize microvascular viability. The procurement team harvests both donor hands en bloc with the distal forearm, preserving maximum vessel, nerve, and tendon length. Simultaneous recipient stump preparation — debridement, vessel isolation, nerve identification, and osteotomy — is performed by a parallel team in an adjacent operating room to minimize total ischemia time.

PHASE 2 — Skeletal Fixation

Rigid skeletal fixation is the foundation of the reconstruction and is performed first to restore anatomical length and rotational alignment. Techniques include:

Подробнее →

Восстановление

STAGE 1 — REMOTE EVALUATION & LISTING (4–8 weeks, conducted from home country)

  • GAF Healthcare coordinates submission of complete medical records, imaging (MRI/CT angiography, nerve conduction studies), and psychiatric evaluation reports to the chosen transplant center
  • Virtual multidisciplinary team (MDT) consultation with transplant surgeon, immunologist, hand therapist, and psychiatrist
  • HLA typing blood samples can be drawn locally and shipped (dry ice, stabilized) to the receiving center's HLA laboratory
  • Formal listing on the hospital's VCA waiting list upon MDT approval; waiting time is variable (months to years depending on donor availability)

STAGE 2 — DONOR ALERT & RAPID MOBILIZATION (24–72 hours)

Подробнее →

Возможные риски

Bilateral hand transplantation carries a distinctive risk profile that combines the hazards of prolonged major microsurgery with the systemic consequences of lifelong immunosuppression — a combination that demands rigorous informed consent and ongoing medical surveillance.

Подробнее →

Почему GAF Healthcare

GAF Healthcare provides end-to-end non-medical coordination for bilateral hand transplant patients traveling to India or the UAE, recognizing that the logistical complexity of an emergency-triggered procedure demands a dedicated, experienced support infrastructure.

Частые вопросы о процедуре «Bilateral Hand Transplant»

What is the cost of bilateral hand transplant (composite tissue allotransplantation) in India versus the UAE?
The total estimated cost of bilateral hand transplantation — covering the surgical procedure, multidisciplinary team fees (transplant-plastic surgeons, anesthesia, microsurgery team), inpatient hospital stay (typically 21–35 days), ICU monitoring, standard immunosuppression induction drugs (ATG/basiliximab, tacrolimus, MMF, prednisolone), and initial inpatient hand therapy — ranges from approximately USD 45,000 to USD 90,000 at NABH/JCI-accredited centers in India (primarily in Mumbai, Chennai, and Hyderabad). At JCI/DHA-accredited centers in Dubai and Abu Dhabi in the UAE, the equivalent package ranges from approximately USD 110,000 to USD 200,000, reflecting higher infrastructure, nursing, and operational costs in the Gulf region. India therefore offers a cost saving of approximately 50–55% for this procedure without a documented compromise in surgical outcomes or implant quality. It is critical to note that neither figure includes the cost of long-term maintenance immunosuppression (tacrolimus + MMF alone can cost USD 8,000–20,000 per year depending on the patient's home country), ongoing rehabilitation beyond the initial inpatient stay, or management of complications. GAF Healthcare provides a detailed, itemized cost estimate specific to each patient's clinical profile before commitment.
How long do I need to stay in the country before I am medically cleared to fly home after bilateral hand transplantation?
A minimum stay of 12 to 16 weeks in the treating country is required before a patient is considered fit for international long-haul air travel following bilateral hand transplantation. This timeline is not arbitrary — it reflects several non-negotiable clinical milestones that must be met before the transplant team issues a fit-to-fly certificate. First, tacrolimus (the cornerstone immunosuppressant) requires 6–10 weeks of dose titration and monitoring to achieve stable trough levels within the therapeutic window (5–15 ng/mL) with an acceptable nephrotoxicity and infection risk profile. Second, all surgical wounds must be fully epithelialized and free of infection before exposure to the pressurized, low-humidity, and potentially immunologically challenging environment of an aircraft cabin. Third, no episode of acute rejection (Banff Grade II or above) should have occurred in the preceding 6 weeks, as this would necessitate escalated immunosuppression and close monitoring incompatible with remote follow-up. Fourth, the patient must demonstrate independence in oral medication management and self-monitoring for early rejection signs. The first 6–8 weeks are additionally occupied by intensive inpatient hand therapy — the critical window for tendon gliding, ROM establishment, and early sensory re-education — which cannot be effectively substituted remotely in the early phase. GAF Healthcare coordinates the formal fit-to-fly assessment, arranges medical escorts if required for the return journey, and provides a 90-day bridging supply of all immunosuppressant medications for the initial period after return to the home country.
What is the success rate of bilateral hand transplantation, and how is success defined?
Based on data from the International Registry on Hand and Composite Tissue Transplantation (IRHCTT) — which has tracked over 100 bilateral and unilateral hand transplant recipients since the procedure's modern revival in 1998 — the overall functional graft survival rate is approximately 85–90% at five years. It is important to understand how 'success' is defined in VCA, as it differs meaningfully from binary graft survival in solid organ transplantation. Vascular patency (graft alive and perfused) is the primary outcome, but functional success is graded using the Carroll Functional Hand Score and the Modified Hand Transplantation Score (MHTS), which assess grip strength, pinch force, two-point discrimination, independence in ADLs, and quality-of-life domains. By these composite metrics, approximately 75–80% of bilateral hand transplant recipients achieve independence in most activities of daily living by 18–24 months, and over 85% report a significant improvement in quality of life compared to their bilateral amputee baseline. Protective sensation (the ability to detect pain, temperature, and gross touch — critical for safety) returns in over 90% of recipients. Discriminative sensation (two-point discrimination ≤10 mm) is achieved in approximately 65–70% of recipients by 24 months. The primary causes of long-term graft failure include chronic rejection vasculopathy (a poorly understood progressive ischemic process) and, in rare cases, voluntary amputation requested by the patient due to psychological non-acceptance — which has occurred in fewer than 5% of reported cases globally. Immunosuppression-related morbidity (particularly nephrotoxicity and infection) remains the most significant determinant of long-term patient — as distinct from graft — survival.

Как GAF Healthcare помогает выбрать лучшую больницу для «bilateral hand transplant» в Хайдарабад, Индия

Найдите лучшие больницы для «bilateral hand transplant» в Хайдарабад, Индия

На этой странице представлено 4 больниц в Хайдарабад, Индия, чтобы вы могли сравнить аккредитацию и специализации в одном месте.

Поддержка, когда она нужна

Отправьте нам свои медицинские отчёты в WhatsApp или по email — наша медицинская команда изучит их и предложит больницу и план лечения.

Прозрачные, всё включено цены

Мы предоставляем единую детализированную смету, покрывающую расходы больницы и проживание — без скрытых платежей.

Организация визы, поездки и проживания

После выбора больницы мы помогаем оформить визовое приглашение, забронировать проживание рядом с больницей и организовать трансфер.

Хотите узнать примерную стоимость лечения? Используйте наш калькулятор стоимости для персональной оценки.

Частые вопросы

Частые вопросы о «Bilateral Hand Transplant» в Хайдарабад, Индия

Сколько больниц направления «Трансплантация печени и гепатобилиарная хирургия» представлено в Хайдарабад, Индия?
Сейчас в Хайдарабад, Индия представлено 4 больниц.
Как вы выбираете больницы для списка?
Больница появляется на этой странице, если направление «Трансплантация печени и гепатобилиарная хирургия» указано среди её специализаций и она находится в Хайдарабад, Индия. Сортировка — по указанному рейтингу (по убыванию), без редакционного рейтинга «лучших».
Сколько стоит лечение в Хайдарабад, Индия?
Стоимость зависит от больницы, города и конкретного случая. Используйте наш калькулятор стоимости для персональной оценки.
🤔

Остались вопросы?

Наша команда готова ответить на вопросы о «Bilateral Hand Transplant» в Хайдарабад, Индия.

Следующий шаг

Отправьте нам свои медицинские отчёты — наша команда предложит больницу и план лечения для «Bilateral Hand Transplant» в Хайдарабад, Индия.

Свяжитесь с нами, если заметите неточность на этой странице.